Charles Schwab Investment Management Inc. grew its position in Harrow, Inc. (NASDAQ:HROW - Free Report) by 195.9% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 251,629 shares of the company's stock after buying an additional 166,602 shares during the period. Charles Schwab Investment Management Inc. owned approximately 0.71% of Harrow worth $11,313,000 as of its most recent SEC filing.
Several other large investors have also bought and sold shares of the company. Private Capital Management LLC raised its holdings in Harrow by 7.8% in the first quarter. Private Capital Management LLC now owns 3,012,393 shares of the company's stock worth $39,854,000 after buying an additional 217,896 shares during the last quarter. First Turn Management LLC purchased a new position in shares of Harrow during the third quarter valued at approximately $14,683,000. Rice Hall James & Associates LLC raised its holdings in shares of Harrow by 23.1% during the third quarter. Rice Hall James & Associates LLC now owns 314,881 shares of the company's stock valued at $14,157,000 after purchasing an additional 59,019 shares during the last quarter. Assenagon Asset Management S.A. purchased a new position in shares of Harrow during the third quarter valued at approximately $8,572,000. Finally, Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Harrow during the third quarter valued at approximately $5,864,000. 72.76% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
HROW has been the subject of several recent research reports. Craig Hallum boosted their target price on shares of Harrow from $45.00 to $65.00 and gave the company a "buy" rating in a research report on Friday, October 4th. Lake Street Capital boosted their target price on shares of Harrow from $45.00 to $55.00 and gave the company a "buy" rating in a research report on Friday, October 4th. Finally, B. Riley cut their target price on shares of Harrow from $73.00 to $69.00 and set a "buy" rating for the company in a research report on Wednesday, December 4th.
Check Out Our Latest Stock Analysis on HROW
Harrow Price Performance
Shares of HROW traded down $2.18 during mid-day trading on Tuesday, reaching $37.77. The stock had a trading volume of 248,839 shares, compared to its average volume of 507,302. The firm has a market cap of $1.35 billion, a price-to-earnings ratio of -42.50 and a beta of 0.69. Harrow, Inc. has a 12 month low of $9.13 and a 12 month high of $59.23. The business has a fifty day moving average of $46.99 and a 200 day moving average of $35.65. The company has a debt-to-equity ratio of 3.23, a quick ratio of 1.44 and a current ratio of 1.55.
About Harrow
(
Free Report)
Harrow, Inc operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc and changed its name to Harrow Health, Inc in December 2018. Harrow Health, Inc was incorporated in 2006 and is headquartered in Nashville, Tennessee.
Read More
Before you consider Harrow, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Harrow wasn't on the list.
While Harrow currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
